Researcher.Life Logo

JOURNAL OF ONCOPATHOLOGY : Impact Factor & More

eISSN: 2053-2091pISSN: 2052-5931
Recommended pre-submission checks
Powered by Paperpal by Editage

JOURNAL OF ONCOPATHOLOGY Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
Overview
Publisher OPTIMAL CLINICAL LTD
Frequency Quarterly
General Details
FrequencyQuarterly
View less

Planning to publish in JOURNAL OF ONCOPATHOLOGY ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in JOURNAL OF ONCOPATHOLOGY

Radium-223 Dichloride (Ra-223) for the Treatment of Metastatic Castration-resistant Prostate Cancer: Optimizing Clinical Practice in Nuclear Medicine Centers
  • 1 Feb 2015
  • The Journal of OncoPathology
Overcoming Phosphatidylinositol 3-Kinase (PI3K) Activation in Breast Cancer: Emerging PI3K Inhibitors
  • 1 Feb 2015
  • The Journal of OncoPathology
The Role of Surgery in Malignant Pleural Mesothelioma
  • 1 Feb 2015
  • The Journal of OncoPathology
The Role of Anti-angiogenic Therapy in the Management of Gynecologic Malignancies: A Review
  • 1 Feb 2015
  • The Journal of OncoPathology
Mechanisms of Resistance to ALK-inhibitor Agents
  • 1 Feb 2015
  • The Journal of OncoPathology
Second Line Treatment in <I>EGFR</I>/<I>ALK</I>-NSCLC Patients
  • 1 Feb 2015
  • The Journal of OncoPathology
Radium-223 Dichloride (Ra-223) for the Treatment of Metastatic Castration-resistant Prostate Cancer: Optimizing Clinical Practice in Nuclear Medicine Centers
  • 1 Feb 2015
  • The Journal of OncoPathology
Overcoming Phosphatidylinositol 3-Kinase (PI3K) Activation in Breast Cancer: Emerging PI3K Inhibitors
  • 1 Feb 2015
  • The Journal of OncoPathology
The Role of Surgery in Malignant Pleural Mesothelioma
  • 1 Feb 2015
  • The Journal of OncoPathology
The Role of Anti-angiogenic Therapy in the Management of Gynecologic Malignancies: A Review
  • 1 Feb 2015
  • The Journal of OncoPathology
Mechanisms of Resistance to ALK-inhibitor Agents
  • 1 Feb 2015
  • The Journal of OncoPathology
Second Line Treatment in <I>EGFR</I>/<I>ALK</I>-NSCLC Patients
  • 1 Feb 2015
  • The Journal of OncoPathology

FAQs on JOURNAL OF ONCOPATHOLOGY